RTSM is an integrated Randomisation and Trial Supply Management solution designed to control patient allocation and investigational product supply in late-phase clinical trials. By combining protocol-driven randomisation with intelligent trial supply management, RTSM ensures unbiased treatment assignment, uninterrupted drug availability, and end-to-end operational visibility—while maintaining strict regulatory compliance across global studies.
Eliminates selection bias through controlled, protocol-driven randomisation processes.
Ensures uninterrupted availability of investigational product at all trial sites.
Reduces manual coordination between enrolment and supply teams through integrated workflows.
Improves accuracy in treatment assignment and inventory utilisation across studies.
Optimises supply forecasting to reduce overstocking, expiry, and drug wastage..
Maintains audit-ready compliance across randomisation and trial supply operations.
faster patient randomisation and enrolment workflows
reduction in supply-related delays and stock-out incidents
improvement in trial supply forecasting accuracy
traceable and auditable randomisation and supply records
